Eli Lilly is proving that being second but better can also pay. Zepbound, the American firm’s weight-loss jab, was approved ...

Eli Lilly said on Sunday its drug Zepbound was superior to Novo Nordisk's Wegovy across five weight-loss targets such as ...

People who take Wegovy appear to be at greater risk for hair loss, according to an early study that hasn't yet been ...

A new study shows that people Zepbound lost about 50% more weight than those using Wegovy. It was the first head-to-head ...

One weight loss injection has been branded more effective than another, after scientists carry out the first ever ...

The head-to-head examination of these weight loss drugs provides doctors with 'robust' data on their effectiveness.

"The highest dose of tirzepatide is five times higher than the approved maximum doses of semaglutide," said Novo Nordisk adding that in the trial, the among of weight loss for Wegovy was lower ...

Novo Nordisk's stock has plummeted over 60%, while also arguably losing market share to Eli Lilly. Click here to find out why ...